MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI technique could slash contrast dye exposure in brain tumor screening
Diagnosis CompletedThis study looked at whether using a much lower dose of gadolinium (a contrast dye) in MRI scans can still spot meningiomas (common brain tumors) as well as the standard full dose. Over 500 adults having a brain MRI for screening or follow-up of meningioma took part. The goal is …
Matched conditions: MENINGIOMA
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated May 17, 2026 02:06 UTC
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 02:03 UTC
-
Brain tumor patients find hope for better sleep in new therapy study
Symptom relief CompletedThis study looked at whether a type of talk therapy called cognitive behavioral therapy for insomnia (CBT-I) can help people with brain tumors who have trouble sleeping. About 70 patients took part to see if the therapy was practical and helpful. The goal is to improve sleep and …
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC
-
Scientists hunt for clues to predict proton therapy success
Knowledge-focused CompletedThis study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …
Matched conditions: MENINGIOMA
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC
-
Tumor DNA map could personalize care for kids with relapsed cancer
Knowledge-focused CompletedThis study looked at whether it's possible to use a child's tumor DNA to choose their next treatment. 186 children with cancers that came back or didn't respond to standard therapy had their tumors analyzed. The goal was to see if this approach could be done quickly enough to gui…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Giselle Sholler • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC